Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 266
7
Diseases
9
Unique genes
0.253
Avg. similarity score
Blast crisis
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Blast crisis
Hyper-immunoglobulin m syndrome
Hyper-immunoglobulin syndrome
hyper-IgM syndrome type 2
Chromosome 22q11.2 microdeletion syndrome
Myelogenous leukemia
hyper-IgM syndrome type 3
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Blast crisis | 5 | 5 | 2 |
| Hyper-immunoglobulin m syndrome | 4 | 4 | 4 |
| Hyper-immunoglobulin syndrome | 4 | 4 | 2 |
| hyper-IgM syndrome type 2 | 3 | 3 | 1 |
| Chromosome 22q11.2 microdeletion syndrome | 2 | 2 | 3 |
| Myelogenous leukemia | 2 | 2 | 3 |
| hyper-IgM syndrome type 3 | 2 | 2 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| AICDA | 4 / 7 | Blast crisis, hyper-IgM syndrome type 2, Hyper-immunoglobulin m syndrome, Hyper-immunoglobulin syndrome |
| BCR | 3 / 7 | Blast crisis, Chromosome 22q11.2 microdeletion syndrome, Myelogenous leukemia |
| CD40 | 3 / 7 | hyper-IgM syndrome type 3, Hyper-immunoglobulin m syndrome, Hyper-immunoglobulin syndrome |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Primary immunodeficiency | KEGG | 4 / 38 | 140× | 1.06e-8 | 9.18e-7 ✓ sig. |
| Chronic myeloid leukemia | KEGG | 4 / 77 | 69.3× | 1.92e-7 | 1.16e-5 ✓ sig. |
| Intestinal immune network for IgA production | KEGG | 3 / 50 | 80.1× | 5.60e-6 | 2.08e-4 ✓ sig. |
| Viral myocarditis | KEGG | 3 / 70 | 57.2× | 1.55e-5 | 4.85e-4 ✓ sig. |
| ErbB signaling pathway | KEGG | 3 / 86 | 46.6× | 2.89e-5 | 8.08e-4 ✓ sig. |
| Frs2-mediated activation | Reactome | 2 / 12 | 222× | 3.28e-5 | 9.00e-4 ✓ sig. |
| Toxoplasmosis | KEGG | 3 / 112 | 35.7× | 6.37e-5 | 1.55e-3 ✓ sig. |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | Reactome | 2 / 18 | 148× | 7.59e-5 | 1.79e-3 ✓ sig. |
| Neurotrophin signaling pathway | KEGG | 3 / 120 | 33.4× | 7.82e-5 | 1.83e-3 ✓ sig. |
| Asthma | KEGG | 2 / 32 | 83.4× | 2.45e-4 | 4.58e-3 ✓ sig. |
| RHO GTPases Activate WASPs and WAVEs | Reactome | 2 / 36 | 74.1× | 3.10e-4 | 5.51e-3 ✓ sig. |
| Allograft rejection | KEGG | 2 / 39 | 68.4× | 3.65e-4 | 6.25e-3 ✓ sig. |
| Pathways in cancer | KEGG | 4 / 533 | 10.0× | 4.04e-4 | 6.76e-3 ✓ sig. |
| Lipid and atherosclerosis | KEGG | 3 / 216 | 18.5× | 4.45e-4 | 7.28e-3 ✓ sig. |
| Malaria | KEGG | 2 / 50 | 53.4× | 6.00e-4 | 9.19e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| isotype switching | GO:0045190 | 3 / 19 | 328× | 7.46e-8 | 9.43e-6 ✓ sig. |
| B cell proliferation | GO:0042100 | 3 / 38 | 164× | 6.46e-7 | 5.80e-5 ✓ sig. |
| cellular response to lipopolysaccharide | GO:0071222 | 4 / 187 | 44.4× | 1.18e-6 | 9.44e-5 ✓ sig. |
| thymus development | GO:0048538 | 3 / 50 | 125× | 1.50e-6 | 1.14e-4 ✓ sig. |
| regulation of immunoglobulin production | GO:0002637 | 2 / 9 | 461× | 7.41e-6 | 4.11e-4 ✓ sig. |
| CD40 signaling pathway | GO:0023035 | 2 / 10 | 415× | 9.26e-6 | 4.92e-4 ✓ sig. |
| Bergmann glial cell differentiation | GO:0060020 | 2 / 11 | 378× | 1.13e-5 | 5.73e-4 ✓ sig. |
| somatic hypermutation of immunoglobulin genes | GO:0016446 | 2 / 14 | 297× | 1.87e-5 | 8.50e-4 ✓ sig. |
| T cell receptor signaling pathway | GO:0050852 | 3 / 121 | 51.5× | 2.16e-5 | 9.55e-4 ✓ sig. |
| regulation of gene expression | GO:0010468 | 4 / 402 | 20.7× | 2.44e-5 | 1.04e-3 ✓ sig. |
| intracellular signal transduction | GO:0035556 | 4 / 471 | 17.6× | 4.54e-5 | 1.68e-3 ✓ sig. |
| positive regulation of macromolecule biosynthetic process | GO:0010557 | 2 / 29 | 143× | 8.32e-5 | 2.64e-3 ✓ sig. |
| positive regulation of endothelial cell apoptotic process | GO:2000353 | 2 / 29 | 143× | 8.32e-5 | 2.64e-3 ✓ sig. |
| positive regulation of canonical NF-kappaB signal transduction | GO:0043123 | 3 / 232 | 26.8× | 1.50e-4 | 4.10e-3 ✓ sig. |
| positive regulation of interleukin-12 production | GO:0032735 | 2 / 43 | 96.6× | 1.84e-4 | 4.77e-3 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Hyper-immunoglobulin m syndrome | Hyper-immunoglobulin syndrome | 0.400 | 2 | 5.06e-8 | 3.92e-7 ✓ sig. |
| Blast crisis | hyper-IgM syndrome type 2 | 0.333 | 1 | 1.30e-4 | 3.90e-4 ✓ sig. |
| hyper-IgM syndrome type 2 | Hyper-immunoglobulin syndrome | 0.333 | 1 | 1.30e-4 | 3.90e-4 ✓ sig. |
| hyper-IgM syndrome type 3 | Hyper-immunoglobulin syndrome | 0.333 | 1 | 1.30e-4 | 3.90e-4 ✓ sig. |
| Blast crisis | Hyper-immunoglobulin syndrome | 0.250 | 1 | 2.60e-4 | 6.40e-4 ✓ sig. |
| hyper-IgM syndrome type 2 | Hyper-immunoglobulin m syndrome | 0.200 | 1 | 2.60e-4 | 6.40e-4 ✓ sig. |
| hyper-IgM syndrome type 3 | Hyper-immunoglobulin m syndrome | 0.200 | 1 | 2.60e-4 | 6.40e-4 ✓ sig. |
| Blast crisis | Myelogenous leukemia | 0.200 | 1 | 3.90e-4 | 8.52e-4 ✓ sig. |
| Blast crisis | Chromosome 22q11.2 microdeletion syndrome | 0.200 | 1 | 3.90e-4 | 8.52e-4 ✓ sig. |
| Blast crisis | Hyper-immunoglobulin m syndrome | 0.167 | 1 | 5.19e-4 | 1.04e-3 ✓ sig. |
| Chromosome 22q11.2 microdeletion syndrome | Myelogenous leukemia | 0.167 | 1 | 5.84e-4 | 1.14e-3 ✓ sig. |